Original Article
Copyright ©2014 Baishideng Publishing Group Inc.
World J Biol Chem. Aug 26, 2014; 5(3): 377-386
Published online Aug 26, 2014. doi: 10.4331/wjbc.v5.i3.377
Figure 3
Figure 3 Histone deacetylase and histone acetyltransferase activity. A: Conventional histone deacetylase (HDAC) activity was not affected by doxorubicin (Dox) treatment; B: Dox decreased hepatic histone acetyltransferase (HAT) activity. aP < 0.050, 0.209 ± 0.006 vs 0.189 ± 0.004.